Over the last decade, harm reduction has proved to be an approach to drugs that saves lives, saves money, and helps respect, protect and fulfil the human rights of people who use drugs.
This Count the Costs briefing explores how the UN seeks to promote the security of its member states through implementing a drug control system that treats the use of certain drugs as an ‘existential threat’ to society.
The objectives of these updated WHO Guidelines are to provide evidence-based recommendations for the treatment of persons with hepatitis C infection using, where possible, all-oral combinations of these new medicines, also called direct-acting antivirals (DAAs).
